Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network

The Lancet Regional Health. Western Pacific · Published 2026-07-28 · DOI 10.1016/j.lanwpc.2026.101938

Free full text

Authors (33)

Ushma Wadia, Peter C. Richmond, Philip N. Britton, Jeremy Carr, Julia E. Clark, Nigel W. Crawford, Te-Yu Hung, Helen S. Marshall, Kristine K. Macartney, Nicholas J. Wood, Brendan J. McMullan, Hannah C. Moore, Paul V. Effler, Allen C. Cheng, Christopher C. Blyth, Tom Kotsimbos, Paul M. Kelly, Mark Holmes, Louis Irving, Stephen Vincent, Sanjaya Senenayake, Tony Korman, Caroline Bartolo, Louise Cooley, Peter Wark, Simon Bowler, Jen Kok, Naomi Runnegar, Daniel M. Fatovich, Grant Waterer, Adam W. Bartlett, Anne Kynaston, Joshua R. Francis

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Wadia, U., Richmond, P., Britton, P., et al. (2026). Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network. The Lancet Regional Health. Western Pacific. https://doi.org/10.1016/j.lanwpc.2026.101938

Related articles